In this study, the ANGPT2 rs1823375 polymorphism appeared to be protective against clinically staged breast cancer and also lymph node disease, while the T-T-C-A-T ANGPT2 haplotype appeared to significantly increase the risk for developing a malignant breast neoplasm. The gene discussed is ANGPT2; the disease is breast carcinoma.